Acute myocardial infarction (AMI) is the leading cause of cardiovascular death and remains
the most common cause of heart failure. Reopening of the occluded artery, ie, reperfusion, is …

The statin family of drugs are safe and effective therapeutic agents for the treatment of
arteriosclerotic cardiovascular disease (CVD). Due to a wide range of health benefits in …

Background Apart from reducing the circulating LDL-c and the number of cardiovascular
cases as well as fatalities, statins have auxiliary non–lipid-related or cholesterol …

Experimental evidence indicates that mesenchymal stromal cells (MSCs) may regulate
tumor microenvironment (TME). It is conceivable that the interaction with MSC can influence …

The histological features of cartilage call attention to the fact that cartilage has a little
capacity to repair itself owing to the lack of a blood supply, nerves, or lymphangion. Stem …

Critical limb ischemia (CLI) causes severe ischemic rest pain, ulcer, and gangrene in the
lower limbs. In spite of angioplasty and surgery, CLI patients without suitable artery inflow or …

The cholesterol‐lowering drugs, statins, possess anti‐inflammatory, antimicrobial and pro‐
osteogenic properties, and thus have been tested as an adjunct to periodontal treatment …

Cell therapy has the potential to improve healing of ischemic heart, repopulate injured
myocardium and restore cardiac function. The tremendous hope and potential of stem cell …

Statins are long known class of medicines and the most frequently prescribed drugs in
cardiovascular pharmacotherapy, widely ordered not only in patients suffering from …

Ischemic heart disease is currently a major cause of mortality and morbidity worldwide.
Nevertheless, the actual therapeutic scenario does not target myocardial cell regeneration …